XENE Q1 2018 Earnings — Xenon Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena

XENEXenon Pharmaceuticals Inc.

$5B

Q1 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

-$6M

Operating Income

-$8M

Net Income

-$4M

EPS (Diluted)

$-0.21

QoQ Revenue Growth

-100.0%

Cash Flow

Operating Cash Flow

-$8M

Free Cash Flow

-$8M

Stock-Based Comp.

$663,000

Balance Sheet

Total Assets

$38M

Total Liabilities

$9M

Stockholders' Equity

$28M

Cash & Equivalents

$17M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$16,000	-100.0%
Gross Profit	-$6M	-$6M	+5.4%
Operating Income	-$8M	-$8M	+2.1%
Net Income	-$4M	-$8M	+50.0%